rimonabant interacts_with CB1 receptor
Evidence from:
primary |
all sources
Evidence (2 sources)
Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies.
(2021)
PMID:32064741
primary
antagonist of the CB1 receptor
confidence: 0.90
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
(2009)
PMID:19322169
cited
selective CB1 receptor antagonist, rimonabant
confidence: 0.97